AB065. P-36. Debio 1347 in patients with cholangiocarcinoma harboring an FGFR gene alteration: preliminary results

BACKGROUND: Cholangiocarcinoma (CCA), an aggressive epithelial neoplasm of biliary tract, presents limited treatment options and poor overall survival. Aberrant fibroblast growth factor receptor (FGFR) signaling has been implicated in CCA carcinogenesis especially in intrahepatic cholangiocarcinoma...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hepatobiliary Surg Nutr
Autors principals: Ng, Matthew C. H., Goyal, Lipika, Bang, Yung-Jue, Oh, Do-Youn, Chao, Tsu-Yi, Cleary, James M., Voss, Martin Henner, Meric-Bernstam, Funda, Iyer, Gopa, Heist, Rebecca Suk, Ishii, Nobuya, Kirpicheva, Yulia, Pokorska-Bocci, Anna, Vaslin, Anne, Hu, Youyou, Zanna, Claudio, Hyman, David, Flaherty, Keith
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2019
Matèries:
Poster Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6421195/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/hbsn.2019.AB065
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars